INM insider transactions
InMed Pharmaceuticals Inc. (INM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
INM insiders
Everyone who has filed a Form 3, 4, 5 or 144 at InMed Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- ADAR1 Capital Management, LLC10% owner, since May 2026+$876K
- Vivo Opportunity, LLC10% owner, since May 2026+$434K
- Shane Aaron JohnsonSr VP & General Manager, since November 2021+$28.3K
- Nicole LemerondDirector, since August 2022
- Neil A KlompasDirector, since October 2024
- Netta JagpalChief Financial Officer, since February 2024
- Michael WoudenbergChief Operating Officer
- John Steven BatheryDirector, since October 2025
- Eric C HsuSr. VP, Pre-Clinical Res/Dev
- Eric A AdamsPresident & CEO, Director+$70.1K
- Andrew HullDirector+$14.6K
- Janet P GroveDirector, since February 2022
- Bryan T BaldasareDirector, since May 2022
- Mancini Alexandra Diane JanetConsultant-$42.31
- Jonathan TeggeOfficer, since December 2022
- Sarah LiOfficer, since November 2022
- Brenda EdwardsOfficer, since April 2022
- William J GarnerDirector
- Adam D. CutlerDirector
- Bruce ColwillOfficer+$14.3K
- Catherine SazdanoffDirector
Recent Form 3, 4, and 5 filings for INM
- Large owner Adar1 Capital Management, Llc bought $34,572 worth of shares (2,640 units at $13.10) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $5 worth of shares (4 units at $1.32) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $1,435 worth of shares (1,087 units at $1.32) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $11,418 worth of shares (8,585 units at $1.33) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $4,051 worth of shares (3,046 units at $1.33) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $35,230 worth of shares (26,489 units at $1.33) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $118,076 worth of shares (91,101 units at $1.30) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $1,555 worth of shares (1,000 units at $1.55) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Vivo Opportunity, Llc bought $31,846 worth of shares (20,546 units at $1.55) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Vivo Opportunity, Llc bought $10,148 worth of shares (6,551 units at $1.55) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Vivo Opportunity, Llc bought $391,555 worth of shares (249,227 units at $1.57) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- New insider Vivo Opportunity, Llc claimed ownership of 541,752 shares (SEC Form 3)3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Large owner Adar1 Capital Management, Llc bought $721,548 worth of shares (468,551 units at $1.54) (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- New insider Adar1 Capital Management, Llc claimed ownership of 331,449 shares (SEC Form 3)3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Klompas Neil A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Jagpal Netta4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Bathery John Steven4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 3 filed by new insider Bathery John Steven3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Klompas Neil A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 3 filed by new insider Klompas Neil A3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Jagpal Netta4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Grove Janet P4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Baldasare Bryan T4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Consultant Mancini Alexandra Diane Janet sold $42 worth of shares (240 units at $0.18), closing all direct ownership in the company (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 3 filed by new insider Jagpal Netta3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Hull Andrew bought $14,625 worth of shares (37,500 units at $0.39), increasing direct ownership by 4,947% to 38,258 units (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Adams Eric A bought $14,922 worth of shares (41,600 units at $0.36), increasing direct ownership by 1,763% to 43,959 units (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Tegge Jonathan4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Grove Janet P4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Baldasare Bryan T4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)